» Articles » PMID: 31282018

Modeling the Regulation of P53 Activation by HIF-1 Upon Hypoxia

Overview
Journal FEBS Lett
Specialty Biochemistry
Date 2019 Jul 9
PMID 31282018
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

As a famous tumor suppressor, p53 is also activated under hypoxic conditions. Hypoxia-inducuble factor 1, HIF-1, is involved in the activation of p53 upon hypoxia. However, how p53 is modulated by the HIF-1 pathway to decide cell fate is less understood. In this work, we developed a network model including p53 and HIF-1 pathways to clarify the mechanism of cell fate decision in response to hypoxia. We found that HIF-1α and p53 are activated under different conditions. Under moderate hypoxia, HIF-1α is activated to induce glycolysis or angiogenesis, and promotes partial accumulation of p53 by inducing PNUTS. Under severe hypoxia, p53 rises to high levels due to ATR-dependent stabilization and promotes Mdm2-dependent HIF-1α degradation. As a result, fully activated p53 triggers apoptosis. Of note, competition for p300 between HIF-1α and p53 plays a key role in regulating their transcriptional activities. This work may advance the understanding of the mechanism for p53 regulation by HIF-1 in the hypoxic response.

Citing Articles

A system-level model reveals that transcriptional stochasticity is required for hematopoietic stem cell differentiation.

Herrera J, Bensussen A, Garcia-Gomez M, Garay-Arroyo A, Alvarez-Buylla E NPJ Syst Biol Appl. 2024; 10(1):145.

PMID: 39639033 PMC: 11621455. DOI: 10.1038/s41540-024-00469-8.


HSPB1 alleviates acute-on-chronic liver failure via the P53/Bax pathway.

Zhang Z, Guo J, Zhu J Open Life Sci. 2024; 19(1):20220919.

PMID: 39071496 PMC: 11282914. DOI: 10.1515/biol-2022-0919.


Shen'ge Formula Protects Cardiac Function in Rats with Pressure Overload-Induced Heart Failure.

Qiu B, Qiao S, Shi X, Shen L, Deng B, Ma Z Drug Des Devel Ther. 2024; 18:1875-1890.

PMID: 38831869 PMC: 11146625. DOI: 10.2147/DDDT.S451720.


Exploring the synergistic pharmacological mechanism of Huoxiang Drink against irritable bowel syndrome by integrated data mining and network pharmacology.

Wang R, Lin Y, Xie H, Li H, Li M, He D Medicine (Baltimore). 2023; 102(39):e35220.

PMID: 37773835 PMC: 10545357. DOI: 10.1097/MD.0000000000035220.


Aggressive variant prostate cancer: A case report and literature review.

Weng X, Lin W, Pan Q, Chen T, Li S, Gu C World J Clin Cases. 2023; 11(26):6213-6222.

PMID: 37731555 PMC: 10507546. DOI: 10.12998/wjcc.v11.i26.6213.